{
    "nctId": "NCT06335550",
    "briefTitle": "Surgical and Patient Reported Outcomes in Robotic Mastectomy",
    "officialTitle": "Pilot Robotic Mastectomy in Singapore (PRoMiSing I) Study: First Safety and Feasibility Prospective Cohort Study in South East Asia",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 29,
    "primaryOutcomeMeasure": "Surgical Outcomes - Operative parameters",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women aged 21-70, with invasive breast cancer, ductal carcinoma in situ (DCIS), Breast Cancer (BRCA) gene or other breast cancer genetic mutation carriers or high risk female patients who are otherwise candidates for conventional NSM/SSM will be eligible for the study. All suitable patients will be offered the option of R-NSM/ R-SSM.\n\nFor patients with breast cancer (invasive or DCIS), selection criteria include but not limited to:\n\n1. Early breast cancer\n2. Tumor size less than 5 cm\n3. No evidence of lymph node metastases\n4. No evidence of skin or chest wall invasion.\n\nExclusion Criteria:\n\n1. Extensive axillary lymph node metastasis (Stage 3B or later)\n2. Heavy smokers (\\>20 cigarettes a day)\n3. High risk patient with severe and poorly controlled co-morbid conditions (include but not limited to diabetes, heart disease, renal failure or liver dysfunction)\n4. Poor performance status or high risk for anaesthesia (ASA 3 and above)\n5. Inflammatory or Locally Advanced Breast Cancer (with or without chest wall or skin invasion)",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}